Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 2
1981 1
1983 4
1984 1
1985 1
1988 1
1989 4
1990 1
1991 2
1992 3
1993 2
1994 2
1995 2
1996 9
1997 4
1998 8
1999 11
2000 13
2001 5
2002 11
2003 13
2004 14
2005 15
2006 13
2007 13
2008 13
2009 14
2010 11
2011 8
2012 11
2013 12
2014 6
2015 11
2016 6
2017 4
2018 5
2019 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

247 results
Results by year
Filters applied: . Clear all
Page 1
Recent developments in A2B adenosine receptor ligands.
Kalla RV, Zablocki J, Tabrizi MA, Baraldi PG. Kalla RV, et al. Among authors: baraldi pg. Handb Exp Pharmacol. 2009;(193):99-122. doi: 10.1007/978-3-540-89615-9_4. Handb Exp Pharmacol. 2009. PMID: 19639280 Review.
alpha-halogenoacrylic derivatives of antitumor agents.
Romagnoli R, Baraldi PG, Cruz-Lopez O, Lopez-Cara C, Preti D. Romagnoli R, et al. Among authors: baraldi pg. Mini Rev Med Chem. 2009 Jan;9(1):81-94. doi: 10.2174/138955709787001640. Mini Rev Med Chem. 2009. PMID: 19149662 Review.
The A3 adenosine receptor: history and perspectives.
Borea PA, Varani K, Vincenzi F, Baraldi PG, Tabrizi MA, Merighi S, Gessi S. Borea PA, et al. Among authors: baraldi pg. Pharmacol Rev. 2015;67(1):74-102. doi: 10.1124/pr.113.008540. Pharmacol Rev. 2015. PMID: 25387804 Review.
The P2X7 receptor as a therapeutic target.
Romagnoli R, Baraldi PG, Cruz-Lopez O, Lopez-Cara C, Preti D, Borea PA, Gessi S. Romagnoli R, et al. Among authors: baraldi pg. Expert Opin Ther Targets. 2008 May;12(5):647-61. doi: 10.1517/14728222.12.5.647. Expert Opin Ther Targets. 2008. PMID: 18410246 Review.
Allosteric enhancers for A1 adenosine receptor.
Baraldi PG, Iaconinoto MA, Moorman AR, Carrion MD, Cara CL, Preti D, López OC, Fruttarolo F, Tabrizi MA, Romagnoli R. Baraldi PG, et al. Mini Rev Med Chem. 2007 Jun;7(6):559-69. doi: 10.2174/138955707780859459. Mini Rev Med Chem. 2007. PMID: 17584155 Review.
Allosteric modulation of A1-adenosine receptor: a review.
Kimatrai-Salvador M, Baraldi PG, Romagnoli R. Kimatrai-Salvador M, et al. Among authors: baraldi pg. Drug Discov Today Technol. 2013 Summer;10(2):e285-96. doi: 10.1016/j.ddtec.2012.08.005. Drug Discov Today Technol. 2013. PMID: 24050280 Review.
Current status of A1 adenosine receptor allosteric enhancers.
Romagnoli R, Baraldi PG, Moorman AR, Borea PA, Varani K. Romagnoli R, et al. Among authors: baraldi pg. Future Med Chem. 2015;7(10):1247-59. doi: 10.4155/fmc.15.65. Future Med Chem. 2015. PMID: 26144263 Review.
Ligands for A2B adenosine receptor subtype.
Baraldi PG, Romagnoli R, Preti D, Fruttarolo F, Carrion MD, Tabrizi MA. Baraldi PG, et al. Curr Med Chem. 2006;13(28):3467-82. doi: 10.2174/092986706779010306. Curr Med Chem. 2006. PMID: 17168717 Review.
247 results